Michael E. Rome

Insider Reports History

Location: San Francisco, CA
Signature: /s/ James P. Reilly, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael E. Rome:

Form 4 holding Director

Kinnate Biopharma Inc.

Security class: Stock Option (right to buy)
Shares / value: 0
Estimated value
Report date: 03 Apr 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Michael E. Rome

4

Kinnate Biopharma Inc.

Report period: 03 Apr 2024
Transactions: 2
Transaction value: $0
Filing time: 05 Apr 2024, 16:55
Role: Director
Next action: Open filing details

4

Kinnate Biopharma Inc.

Report period: 13 Jun 2022
Transactions: 1
Transaction value: $0
Filing time: 15 Jun 2022, 17:00
Role: Director
Next action: Open filing details

3

Theseus Pharmaceuticals, Inc.

Report period: 06 Oct 2021
Transactions: 0
Transaction value: $0
Filing time: 06 Oct 2021, 19:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .